Alzheimer's

Views & Analysis

World Alzheimer's Day: latest research and a carer's perspec...

On World Alzheimer’s Day, pharmaphorum looks at statistics, current research and the impact of dementia on families.

News

Closeup of X-ray photography of human brain

Biogen drug shows potential in Alzheimer's

Phase 1b trial shows aducanumab clears brain plaques.

News

Lilly/AZ's Alzheimer's drug gets fast US development

AZD3293 gets Fast Track designation.

Views & Analysis

After 2015's ‘breakthrough’ year for pharma approvals, will ...

Roche's MS drug is among major drugs still to come in 2016.

News

Lilly pays AstraZeneca $100m as Alzheimer's drug enters phas...

AstraZeneca and Eli Lilly are to continue with a pivotal phase 2/3 study of a key pipeline drug, AZD3293 for early Alzheimer's disease, after interim safety data boosted confidence in the d

World Alzheimer's Day: latest research and a carer's perspec...

Biogen drug shows potential in Alzheimer's

Lilly/AZ's Alzheimer's drug gets fast US development

After 2015's ‘breakthrough’ year for pharma approvals, will ...

Lilly pays AstraZeneca $100m as Alzheimer's drug enters phas...

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's

Editor's Picks